Skip to main content
Market intelligence
ALLOHealthcare

Allogene Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 21, 2026Earl Martin DouglasSVP, General CounselSale29,697$2.12$62,958
Apr 21, 2026Annie YoshiyamaSVP, FinanceSale9,586$2.31$22,144
Mar 16, 2026Benjamin Machinas BeneskiSVP, Chief Technical OfficerSale4,835$2.47$11,942